cgi-1746 and Leukemia--Myeloid--Acute

cgi-1746 has been researched along with Leukemia--Myeloid--Acute* in 1 studies

Other Studies

1 other study(ies) available for cgi-1746 and Leukemia--Myeloid--Acute

Article	Year
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML. Leukemia, 2016, Volume: 30, Issue:3 Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Apoptosis; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; fms-Like Tyrosine Kinase 3; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Organ Specificity; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Signal Transduction; STAT5 Transcription Factor	2016

Article

Year

Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.

Leukemia, 2016, Volume: 30, Issue:3

Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Apoptosis; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; fms-Like Tyrosine Kinase 3; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Organ Specificity; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Signal Transduction; STAT5 Transcription Factor

2016